These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6252931)

  • 1. Analysis of clonogenic human brain tumour cells: preliminary results of tumour sensitivity testing with BCNU.
    Rosenblum ML; Dougherty DA; Deen DF; Hoshino T; Wilson CB
    Br J Cancer Suppl; 1980 Apr; 4():181-5. PubMed ID: 6252931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentials and limitations of a clonogenic cell assay for human brain tumors.
    Rosenblum ML; Dougherty DV; Deen DF; Wilson CB
    Cancer Treat Rep; 1981; 65 Suppl 2():61-6. PubMed ID: 7346148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
    Ng WH; Wan GQ; Too HP
    J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
    Kuo YC; Liang CT
    Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.
    Rozental JM; Cohen JD; Mehta MP; Levine RL; Hanson JM; Nickles RJ
    J Neurooncol; 1993 Jan; 15(1):57-66. PubMed ID: 8384254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD
    Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitivity testing for human brain tumors.
    Rosenblum ML
    Prog Clin Biol Res; 1980; 48():259-76. PubMed ID: 7208520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of high-dose intraarterial BCNU.
    Kleinschmidt-DeMasters BK; Geier JM
    Surg Neurol; 1989 Jun; 31(6):435-43. PubMed ID: 2541513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related chemosensitivity of stem cells from human malignant brain tumours.
    Rosenblum ML; Gerosa M; Dougherty DV; Reese C; Barger GR; Davis RL; Levin VA; Wilson CB
    Lancet; 1982 Apr; 1(8277):885-7. PubMed ID: 6122104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple pulmonary lesions in a patient treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme.
    Bellot PA; Valdiserri RO
    Cancer; 1979 Jan; 43(1):46-50. PubMed ID: 216479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential.
    Rosenblum ML; Gerosa MA; Wilson CB; Barger GR; Pertuiset BF; de Tribolet N; Dougherty DV
    J Neurosurg; 1983 Feb; 58(2):170-6. PubMed ID: 6848672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione.
    Ali-Osman F; Caughlan J; Gray GS
    Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of sequential computed tomography in the multimodality treatment of glioblastoma multiforme.
    Salcman M; Levine H; Rao K
    Neurosurgery; 1981 Jan; 8(1):15-9. PubMed ID: 6259550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of cultured human brain tumors to nitrosoureas: correlation with clinical data.
    Kornblith PL; Smith BH; Leonard LA
    Cancer; 1981 Jan; 47(2):255-65. PubMed ID: 7459816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
    Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The multicentric glioblastoma multiforme].
    Dietz R; Schanen G; Kramann B
    Rontgenblatter; 1990 Dec; 43(12):543-5. PubMed ID: 1962894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.